Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Could cannabis be used to treat kidney failure among diabetics?

Aberdeen University
Aberdeen University

Researchers at a north-east university are exploring whether cannabis could be used to treat kidney failure caused by diabetes.

Currently, about 40% of people with diabetes go on to develop kidney failure.

Now, Aberdeen University academics are examining if new synthetic cannabinoid compounds could be used to help kidneys respond more effectively to insulin.

Active ingredients in the cannabis plant are already known to help treat a number of conditions such as rheumatoid arthritis.

This is achieved when the plant’s cannibanoids act on the body’s own cannibanoid receptors.

These are made up of CB1 receptors found in the brain, and CB2s which are found in other tissues.

Both types of receptors are also found in the kidney cells, with CB1 increased in patients suffering from kidney failure and CB2 decreased as a result of the same condition.

Dr Mirela Delibegovic is leading the research team behind the project, which is being funded by Diabetes UK.

“New evidence suggests that to combat diabetes and its complications, we want to block CB1 receptors and activate CB2, and we think these novel compounds could allow us to do this,” she explained.

“Diabetic nephropathy can lead to patients requiring dialysis or renal transplantation, therefore identifying if novel cannabinoid compounds can be used to ameliorate this disease is of upmost importance.

“There are already some cannabanoids used to treat inflammatory diseases like rheumatoid arthritis, so these compounds could be taken relatively fast from bench-side to bed-side.”

The team is collaborating with Bristol University, which has provided access to human cells from patients with kidney disease.

The new cannabinoids will be used to see if they improve insulin sensitivity in these cells.

The ones that show improvement in human cell lines will be tested in mouse models of diabetes.

The launch of the study coincides with World Diabetes Day today, organised by the International Diabetes Federation.

The university’s Kings College is among a number of buildings across the UK and further afield which will light up blue in recognition of the event.